3,4-Dihydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one

Catalog No.: 
ACKNBG590
CAS No.: 
50624-06-1
Molecular Formula: 
C13H12O4
Molecular Weight: 
232.24
3,4-Dihydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg92%
1g92%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,4-Dihydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one
IUPAC Name3,4-dihydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one
MDL No.MFCD00229561
Molecular FormulaC13H12O4
Molecular Weight232.24
SMILESO=C1C2=C(CCCC2)C3=C(O1)C(O)=C(O)C=C3
InChI KeyMXBLPWAUEWFCJU-UHFFFAOYSA-N
Synonym3,4-Dihydroxy-7,8,9,10-tetrahydro-6H-benzo[c]-chromen-6-one;3,4-dihydroxy-7,8,9,10-tetrahydrobenzo[c]chromen-6-one;BB_SC-4360;Oprea1_647310;3,4-dihydroxy-6H,7H,8H,9H,10H-cyclohexa[c]chromen-6-one;6H-Dibenzo[b,d]pyran-6-one, 7,8,9,10-tetrahydro-3,4-dihydroxy-
CAS No.50624-06-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACKNBG590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKNBG590 route product structure diagram
    ACKNBG59050624-06-1
Inquiry

2. ACKNBG590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKNBG590 route product structure diagram
    ACKNBG59050624-06-1
Inquiry

3. ACKNBG590 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKNBG590 route product structure diagram
    ACKNBG59050624-06-1
Inquiry

Comments (0)